Form 4 for IMMX Immix Biopharma, Inc.
Accepted 2023-09-08 00:00:00 ET · period of report 2023-09-06 · accession 0001493152-23-032150 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-09-08 | 2023-09-06 | IMMX | Marquet Magda | Dir | P - Purchase | $2.47 | +9,000 | 20.0K | +82% | +$22.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-06 | P | A | 9,000 | $2.47 | 20,000 | I Via ALMA Life Sciences, LLC | — | — |